Clinical Study About Blood Pressure Measurement Efficacy on Multifunction KEITO
NCT ID: NCT01359748
Last Updated: 2014-07-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2011-03-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trial of Blood Pressure Monitor in Conformance With the ANSI/AAMI ISO 81060-2 Standard
NCT03588559
Validation Study of CONTEC08C Electronic Sphygmomanometer
NCT06457568
Clinical Trial of YuWell YE660D Blood Pressure Monitor in General Population According to the ISO 81060-2:2018
NCT04931264
Larsen & Toubro (L&T) Noninvasive Blood Pressure Module Performance Validation
NCT01097603
Clinical Trial of YuWell YE900 Electronic Sphygmomanometer
NCT04379323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One of the most important parameter is the Blood Pressure (BP)measurement. To warrant their efficacity and accuracy, was essential to perform this trial to ensure that the measurements obtained meet with the requirements of the specific U.S. standard about Non-invasive sphygmomanometers.
By Validating with auscultatory reference sphygmomanometer, as defined on the ANSI/AAMI/ISO 81060-2:2009 , we have been intending to demonstrate that the multifunction KEITO devices, particularly about the Blood Pressure (BP) Measurement, have the same efficacy and accuracy as the conventional auscultatory sphygmomanometers.
To include most of the groups of Blood Pressure (BP) measurements types on this clinical trial, a great variety of BP ranges have been selected, always in accordance with the standard.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wrist Size <= 14.25 Cm
* Blood pressure measured using the reference sphygmomanometer.
* Blood pressure measured using the Sphygmomanometer under test.
Reference sphygmomanometer
\* USED Audible Korotkoff (K5)for Auscultatory sphygmomanometer.
Sphygmomanometer under test
Electronic Oscillometric method.
Wrist Size >=14.26 <16.50 Cm
* Blood pressure measured using the reference sphygmomanometer.
* Blood pressure measured using the Sphygmomanometer under test.
Reference sphygmomanometer
\* USED Audible Korotkoff (K5)for Auscultatory sphygmomanometer.
Sphygmomanometer under test
Electronic Oscillometric method.
Wrist size >=16.5 <17.75 Cm
* Blood pressure measured using the reference sphygmomanometer.
* Blood pressure measured using the Sphygmomanometer under test.
Reference sphygmomanometer
\* USED Audible Korotkoff (K5)for Auscultatory sphygmomanometer.
Sphygmomanometer under test
Electronic Oscillometric method.
Wrist Size >=17.75 Cm
* Blood pressure measured using the reference sphygmomanometer.
* Blood pressure measured using the Sphygmomanometer under test.
Reference sphygmomanometer
\* USED Audible Korotkoff (K5)for Auscultatory sphygmomanometer.
Sphygmomanometer under test
Electronic Oscillometric method.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reference sphygmomanometer
\* USED Audible Korotkoff (K5)for Auscultatory sphygmomanometer.
Sphygmomanometer under test
Electronic Oscillometric method.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 5% of the readings shall have Systolic BP\<=100 mmHg
* At least 5% of the readings shall have Systolic BP\>=160 mmHg
* At least 20% of the readings shall have Systolic BP\>=140 mmHg
* At least 5% of the readings shall have Diastolic BP\<=60 mmHg
* At least 5% of the readings shall have Diastolic BP\>=100 mmHg
* At least 20% of the readings shall have Diastolic BP\>=85 mmHg
Exclusion Criteria
18 Years
83 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aguiflai Iberica, S.L.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angel P Ferre, Engineer
Role: STUDY_DIRECTOR
Francisco B Contreras, Technician
Role: STUDY_CHAIR
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K8-BP-31032011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.